Pharmacodynamics and pharmacokinetics of antibacterial drugs in the management of febrile neutropenia
- 31 October 2008
- journal article
- review article
- Published by Elsevier BV in The Lancet Infectious Diseases
- Vol. 8 (10), 612-620
- https://doi.org/10.1016/s1473-3099(08)70228-7
Abstract
No abstract availableThis publication has 102 references indexed in Scilit:
- Tobramycin once versus three times daily, given with penicillin G, to febrile neutropenic cancer patients in Norway: a prospective, randomized, multicentre trialJournal of Antimicrobial Chemotherapy, 2007
- Teicoplanin in Patients with Acute Leukaemia and Febrile NeutropeniaClinical Pharmacokinetics, 2004
- Clinical Pharmacokinetics and Pharmacodynamics of IsepamicinClinical Pharmacokinetics, 2000
- Pharmacokinetics of meropenem in febrile neutropenic patientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1997
- Influence of malignancy on the pharmacokinetics of vancomycin in infants and childrenThe Pediatric Infectious Disease Journal, 1995
- The Importance of Pharmacokinetic/Pharmacodynamic Surrogate Markers to OutcomeClinical Pharmacokinetics, 1995
- Pharmacokinetic parameters of vancomycin for therapeutic regimens in neutropenic adult patientsInternational Journal of Bio-Medical Computing, 1994
- Failure of teicoplanin therapy in two neutropenic patients with staphylococcal septicemia who recovered after administration of vancomycinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1990
- Once-daily versus thrice-daily administration of netilmicin in combination therapy ofPseudomonas aeruginosa infection in a man-adapted neutropenic animal modelEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989
- Gentamicin Volumes of Distribution in Patients with Hematologic DisordersThe New England Journal of Medicine, 1988